Detalhe da pesquisa
1.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060201
2.
Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancer.
Prostate
; 81(1): 50-57, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986884
3.
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Value Health
; 24(12): 1737-1745, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838271
4.
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805).
Prostate
; 80(16): 1429-1437, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949185
5.
Biological and therapeutic advances in the pursuit of effective immunotherapy for prostate cancer.
Curr Opin Urol
; 30(1): 30-35, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31609776
6.
Precision medicine for prostate cancer: An international perspective.
Urol Oncol
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614920
7.
Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer.
J Circ Biomark
; 13: 1-6, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415240
8.
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
Curr Oncol
; 30(1): 923-937, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661719
9.
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment.
Am Soc Clin Oncol Educ Book
; 43: e390166, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220335
10.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Res Sq
; 2023 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798177
11.
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Prostate Cancer Prostatic Dis
; 25(2): 199-207, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108647
12.
Accumulation of copy number alterations and clinical progression across advanced prostate cancer.
Genome Med
; 14(1): 102, 2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059000
13.
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants.
Mol Cancer Res
; 19(7): 1137-1145, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33863813
14.
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Eur Urol Focus
; 7(5): 1130-1136, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032968
15.
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.
Nat Cancer
; 2(4): 444-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899001
16.
Nursing Implications of Recent Changes in Management Practices for Metastatic Prostate Cancer.
Semin Oncol Nurs
; 36(4): 151047, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709484
17.
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.
Nat Protoc
; 15(8): 2503-2518, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591768
18.
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol
; 38(12): 1322-1331, 2020 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877087
19.
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
Cancer Med
; 9(1): 116-124, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31715650
20.
Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons.
Eur Urol Focus
; 5(2): 165-167, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559064